Explore CD25/IL-2RA/IL2RA gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
Target ID |
GM-T03313
|
Target Name |
CD25/IL-2RA/IL2RA
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
3559
|
Gene ID |
100070292 (Equus caballus), 16184 (Mus musculus), 25704 (Rattus norvegicus), 281861 (Bos taurus) 3559 (Homo sapiens), 403870 (Canis lupus familiaris), 493953 (Felis catus), 574300 (Macaca mulatta)
|
Target Alternative Names |
IL2RA,Il2ra,CD25,Il2r,Ly-43,IL2RAC,p55,IL2R,IMD41,TCGFR,IDDM10,IL-2RA
|
Uniprot Accession |
P01590,P26897,P12342,P01589,O62802,P41690,Q5MNY4
|
Uniprot Entry Name |
|
Protein Sub-location |
Transmembrane Protein
|
Category |
Therapeutics Target, Immuno-oncology Target, INN Index
|
Disease |
cancer, Ovary Cancer
|
Disease from KEGG |
Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer
|
Gene Ensembl |
ENSECAG00000018057, ENSMUSG00000026770, ENSBTAG00000020892, ENSG00000134460, ENSCAFG00845002030, ENSMMUG00000015151
|
Target Classification |
Checkpoint-Immuno Oncology
|
Pre-made viral vector of CD25/IL-2RA/IL2RA cDNA Clones/ORF Plasmid
CD25/IL-2RA/IL2RA siRNA/miRNA/oligo for RNA interfence (RNAi)
Cat No. | Product Name | GeneID | Species | Grade | Detail |
---|
pGMoligo3559 | Pre-made Human IL2RA/p55/CD25 siRNA oligo Duplex | 3559 | Human | In-vitro grade; in-vivo grade | Detail |
pGMoligo25704 | Pre-made Rat Il2ra/IL2RAC siRNA oligo Duplex | 25704 | Rat | In-vitro grade; in-vivo grade | Detail |
pGMoligo16184 | Pre-made Mouse Il2ra/CD25/Il2r siRNA oligo Duplex | 16184 | Mouse | In-vitro grade; in-vivo grade | Detail |
pGMoligo574300 | Pre-made Cynomolgus/Rhesus macaque IL2RA/IL-2RA siRNA oligo Duplex | 574300 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
pGMoligo493953 | Pre-made Cat/Feline IL2RA/CD25 siRNA oligo Duplex | 493953 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
pGMoligo403870 | Pre-made Dog/Canine IL2RA/CD25/IL-2RA siRNA oligo Duplex | 403870 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
pGMoligo281861 | Pre-made Bovines/Cattle IL2RA/CD25 siRNA oligo Duplex | 281861 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
pGMoligo100070292 | Pre-made Equine/Horse IL2RA/CD25 siRNA oligo Duplex | 100070292 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CD25/IL-2RA/IL2RA antibody/GMab
Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
---|
GM-Tg-hg-T03313-Ab | Human | Anti-Human CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-rg-T03313-Ab | Rat | Anti-Rat CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-mg-T03313-Ab | Mouse | Anti-Mouse CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-cynog-T03313-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-felg-T03313-Ab | Cat/Feline | Anti-Cat/Feline CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-cang-T03313-Ab | Dog/Canine | Anti-Dog/Canine CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-bovg-T03313-Ab | Bovines/Cattle | Anti-Bovines/Cattle CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-equg-T03313-Ab | Equine/Horse | Anti-Equine/Horse CD25/IL-2RA/IL2RA monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CD25/IL-2RA/IL2RA VLP (virus-like particle)
Cat No. | Species | Antigen Name | Expression Platform | Detail |
---|
GM-Tg-hg-T03313-Ag | Human | Human CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-rg-T03313-Ag | Rat | Rat CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-mg-T03313-Ag | Mouse | Mouse CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-cynog-T03313-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-felg-T03313-Ag | Cat/Feline | Cat/Feline CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-cang-T03313-Ag | Dog/Canine | Dog/Canine CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-bovg-T03313-Ag | Bovines/Cattle | Bovines/Cattle CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-equg-T03313-Ag | Equine/Horse | Equine/Horse CD25/IL-2RA/IL2RA VLP (virus-like particle) | HEK293 | Products Developing |